CoChat

Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics

Moludi, Jalal, Maleki, Vahid, Jafari‐Vayghyan, Hamed, Vaghef‐Mehrabany, Elnaz, Alizadeh, Mohammad · 2020 · Clinical and Experimental Pharmacology and Physiology
Cited by 111

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Translocation of microbiome‐derived lipopolysaccharide (LPS) to the bloodstream (metabolic endotoxaemia) is associated with a significantly increased risk of cardiovascular diseases (CVD); however, the direction of this association is not fully understood. It has been revealed by some studies that alterations in the intestinal microbiota (dysbiosis) lead to increased intestinal permeability and translocation of LPS to the blood circulation. LPS may trigger toll‐like receptor 4‐ (TLR‐4) mediated inflammatory responses; this could lead to a chronic low‐grade pro‐inflammatory condition named metabolic endotoxaemia (ME), which is typically observed in CVD patients. ME is promoted by increased intestinal permeability. Moreover, dysbiosis leads to production of trimethylamine‐N‐oxide (TMAO), a gut bacterial metabolite suggested as a new risk factor in CVD development. Probiotics, extensively reviewed for decades, are live microorganisms which, when taken in adequate amounts, have beneficial effects on the host metabolism. Prebiotics are a type of dietary fibre that act as nourishment for the good bacteria in the gut and decrease the population of pathogen bacteria that produce greater amounts of endotoxins. Although an association has been postulated between ME and CVD, the results of studies investigating the role of antibiotic therapy in preventing the disease have been inconsistent. In this review, we discuss how prebiotics and probiotics modulate gut microbiota and consequently might help with prevention and/or treatment of CVD associated with ME.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1440-1681.13250

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 111

Metadata

Authors
Moludi, J., Maleki, V., Jafari‐Vayghyan, H., Vaghef‐Mehrabany, E., & Alizadeh, M.
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
2020-01-24
Volume
47
Issue
6
Pages
927-939
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W2996902552
Cited by
111
References
32
FWCI
1.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics. https://app.cochat.ai/papers/10.1111/1440-1681.13250
The paper
Moludi, J., Maleki, V., Jafari‐Vayghyan, H., Vaghef‐Mehrabany, E., & Alizadeh, M. (2020). Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.13250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.